What is the treatment approach for a suspected Calcium-Related Blood Stream (CRBS) infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Catheter-Related Bloodstream Infection (CRBSI)

For suspected CRBSI, immediately obtain paired blood cultures from both the catheter and a peripheral vein before initiating empirical antimicrobial therapy, then remove the catheter if the patient has severe sepsis, S. aureus, Pseudomonas, Candida, or persistent bacteremia beyond 72 hours despite appropriate antibiotics. 1

Diagnostic Approach

Obtain paired blood cultures from the catheter and a peripheral vein before starting any antibiotics. 1, 2 A differential time to positivity (DTP) of ≥2 hours between catheter and peripheral samples is highly sensitive and specific for CRBSI. 1, 2 If peripheral access is impossible, draw two blood samples from different catheter lumens at different times. 2, 3

  • Disinfect the catheter hub with alcohol, alcoholic chlorhexidine (>0.5%), or tincture of iodine before drawing cultures. 2, 4
  • Day 1 of treatment duration is defined as the first day negative blood cultures are obtained. 1

Immediate Catheter Management Decision

Mandatory Catheter Removal 1

Remove the catheter immediately if ANY of the following are present:

  • Severe sepsis, hypotension, or organ failure 1, 2
  • S. aureus bacteremia (only 20% success rate with catheter salvage) 1
  • Pseudomonas aeruginosa infection 1
  • Candida species infection 1, 4
  • Mycobacterial infection 1
  • Suppurative thrombophlebitis or endocarditis 1
  • Tunnel or pocket infection 4
  • Persistent bacteremia >72 hours despite appropriate antimicrobial therapy 1

For short-term (non-tunneled) catheters, also remove for gram-negative bacilli, enterococci, fungi, and mycobacteria. 1, 3

Catheter Salvage May Be Attempted 1

Only in clinically stable patients with limited venous access and infections caused by:

  • Coagulase-negative staphylococci 1, 2
  • Corynebacterium jeikeium 1
  • Acinetobacter baumannii 1
  • Stenotrophomonas maltophilia 1

Requirements for salvage attempt: Use both systemic antibiotics AND antibiotic lock therapy, obtain repeat blood cultures at 72 hours, and remove catheter if cultures remain positive. 1

Empirical Antimicrobial Therapy

Gram-Positive Coverage 1

  • Vancomycin is the first-line empirical agent in settings with elevated MRSA prevalence. 1, 3
  • Switch to daptomycin if vancomycin MIC values >2 μg/mL or in institutions with high prevalence of such strains. 1
  • Do NOT use linezolid empirically (only after proven bacteremia). 1, 3

Gram-Negative Coverage 1

Base selection on local antibiogram and severity:

  • Fourth-generation cephalosporin, carbapenem, or β-lactam/β-lactamase combination ± aminoglycoside 1, 3
  • Use combination therapy for neutropenic patients, severe sepsis, or known colonization with multidrug-resistant organisms like Pseudomonas. 1

Fungal Coverage 1

Empirical antifungal therapy is indicated for septic patients with:

  • Total parenteral nutrition 1
  • Prolonged broad-spectrum antibiotic use 1
  • Hematologic malignancy 1
  • Bone marrow or solid-organ transplant 1
  • Femoral catheterization 1
  • Candida colonization at multiple sites 1

Use an echinocandin (caspofungin, micafungin, anidulafungin) for empirical treatment. 1, 3 Fluconazole may be used only if no azole exposure in prior 3 months and low risk of C. krusei or C. glabrata. 1

Pathogen-Specific Treatment Duration

Coagulase-Negative Staphylococci 1, 2

  • Catheter removed: 5-7 days of IV antibiotics 2
  • Catheter retained: 10-14 days IV antibiotics PLUS antibiotic lock therapy 1, 2
  • Remove catheter if persistent fever/bacteremia after these measures (occurs in 20% of cases). 1

S. aureus 1, 2

  • Uncomplicated (catheter removed): Minimum 10-14 days IV antibiotics after catheter removal 1
  • Complicated infections: 4-6 weeks of therapy 1, 2
  • Perform transesophageal echocardiography (TEE) to rule out endocarditis in all S. aureus bacteremia cases. 2, 4
  • Antibiotic options based on sensitivities: penicillin, first-generation cephalosporin, vancomycin, daptomycin, or linezolid. 1

Enterococcus 1

  • Susceptible isolates: Ampicillin or vancomycin alone or with aminoglycoside 1
  • Resistant isolates: Linezolid or daptomycin 1
  • Catheter retained: 7-14 days IV treatment plus antibiotic lock therapy 1

Candida Species 1

  • Mandatory catheter removal 1
  • Continue antifungal therapy for 14 days after first negative blood culture and resolution of symptoms 1

Special Populations

Hemodialysis Patients 1

  • Always remove catheter for S. aureus, Pseudomonas, or Candida infections. 1
  • If absolutely no alternative sites exist, exchange over guidewire as salvage strategy (combined with antibiotics). 1
  • A new long-term catheter can be placed once blood cultures are negative. 1
  • Draw peripheral blood cultures from vessels NOT intended for future fistula creation (e.g., hand veins). 1

Pediatric Patients 1

  • Indications for catheter removal are similar to adults unless no alternative access exists. 1
  • Monitor closely with clinical evaluation and repeat blood cultures if catheter retained. 1
  • Remove device if clinical deterioration or persistent/recurrent CRBSI occurs. 1

Critical Pitfalls to Avoid

  • Never delay obtaining blood cultures before starting antibiotics - this complicates diagnosis and pathogen identification. 2, 3, 4
  • Never attempt catheter salvage with S. aureus, Pseudomonas, or Candida - failure/delay increases mortality and hematogenous complications. 1, 2
  • Do not routinely replace CVCs or perform guidewire exchanges to prevent infection - this does not reduce CRBSI rates and increases insertion complications. 1, 4
  • Do not use linezolid empirically - reserve for proven infections only. 1, 3
  • Do not ignore local antibiogram data - empirical gram-negative coverage must reflect institutional resistance patterns. 1, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Catheter-Related Bloodstream Infections (CRBSI)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of PICC Line Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Catheter-Related Bloodstream Infections (CRBSI)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.